01 — At a Glance
The Goop Factory That Silently Conquered The Foundry
- 52-Week High / Low₹6,846 / ₹3,251
- FY25 Revenue (Full Year)₹643 Cr
- FY25 PAT (Full Year)₹75 Cr
- Full-Year EPS (FY25)₹95.91
- Annualised EPS (Q4×4)₹66.88
- Book Value₹1,375
- Price to Book3.82x
- Dividend Yield0.49%
- Debt / Equity0.00x
- MCIL Acquisition₹654 Cr (Nov 2025)
The Setup: Foseco India closed FY25 with ₹643 crore revenue (+22.6% YoY), ₹75 crore PAT, and 17.4% ROCE. But here’s the kicker — in November 2025, they acquired 75% of Morganite Crucible (MCIL) for ₹654 crore, becoming the only supplier offering products across the entire foundry process for both ferrous and non-ferrous casting. The stock is up 46% in one year. Meanwhile, everyone’s busy tweeting about AI and crypto. Priorities, apparently.
02 — Introduction
Yes, Goop. Metallurgical Goop. And It’s Bigger Than Your Portfolio.
Let’s start with a confession: before researching Foseco, I thought “foundry chemicals” were something you’d find in a mining accident lawsuit. Turns out, they’re the unsung heroes of every casting facility on Earth. Cars get their engine blocks here. Railway components. Heavy machinery. Petrochemical pipelines. Even those massive turbines that make your expensive electricity.
Foseco sells coatings, additives, filtration systems, and pouring compounds that prevent castings from looking like a melted birthday cake. They hold roughly 50%+ of India’s foundry chemicals market. They’re the only supplier offering integrated solutions across the entire foundry value chain for both ferrous (steel) and non-ferrous (aluminium, copper, etc.) casting — which is basically the equivalent of being the Jio of industrial additives, but for metal.
What nobody tells you: industrial specialty chemicals are the most boring, most profitable segment in Indian manufacturing. These aren’t trending on Twitter. They’re trending on foundry shop floors where actual wealth gets created.
FY25 delivered revenue growth of 22.6% and PAT growth of 18.9%. The stock returned 46% in one year. And then, boom — November 2025, they closed the Morganite Crucible acquisition, instantly becoming a vertically integrated powerhouse. Management’s tone on the concall: confident but measured, like someone who just closed a deal on their first try and doesn’t want to jinx it.
Concall Insight (Mar 2026): “The MCIL acquisition represents a strategic move toward end-to-end foundry solutions. Our installed base now extends across crucibles, filters, coatings, and additives — four adjacent high-margin product categories.” — Foseco Management. Translation: we just bought our way to being indispensable.
03 — Business Model: WTF Do They Even Do?
They Make Liquid Wizardry That Fixes Hot Metal Problems.
Here’s how the business works: Foundries melt metal at insane temperatures. The melted metal does what melted metal does — it wants to create impurities, form gas bubbles, and generally cause chaos. Foseco’s job? Prevent the chaos. They supply coatings for molds, filtration systems that trap impurities, additives that control grain structure, and pouring compounds that regulate metal flow. Essentially, they’re the nanny service for angry, 1,600-degree-Celsius liquid metal.
Revenue split: 94% domestic, 6% exports (as of FY23). But here’s the thing — management is aggressive on export expansion. FY25 numbers should show improvement. The company has two manufacturing facilities (Pune and Pondicherry) and imports specialized products from group locations in the UK, Belgium, and other global Foseco operations. It’s a classic “global parent, local execution” model.
Key product categories: INSTA Coatings (water-based, 30% cost reduction), SEMCO FDC for flow coating (50% energy savings), Rotoclene (rotary stirring for impurity capture), and Stelex (3D-printed filters for precision pore sizing). These aren’t household names. They’re the names that foundry engineers know and swear by. And in B2B, that’s everything.
Customer base spans automotive (your car’s engine block), railways (the thing that’ll hit you if you ignore the warning), heavy transport, construction, petrochemicals, and power generation. Concentrated customer base? Somewhat. But industrial demand is sticky — once a foundry approves your chemistry, switching costs are brutal.
Royalty Note: Foseco pays ~5% of revenue as royalty to Foseco International, UK (the global parent). That’s ₹32 crore in FY25. It’s the price of access to global R&D and the Foseco brand, which carries weight in foundry circles worth its weight in, well, cast iron.
💬 Drop a comment: Ever noticed the quality of your car’s engine block? That’s Foseco’s handiwork. Did you pay attention? Didn’t think so.
04 — Financials Overview
FY25: The Numbers That Nobody Expected to Grow This Much
Result type: Full-Year FY25 Results | Q4 FY25 EPS: ₹16.72 | Full-year FY25 EPS: ₹95.91 | Annualised Q4 EPS (×4): ₹66.88
| Metric (₹ Cr) |
Q4 FY25
Dec 2025 |
Q4 FY24
Dec 2024 |
Q3 FY25
Sep 2025 |
YoY % |
QoQ % |
| Revenue | 187 | 136 | 151 | +37.5% | +23.8% |
| Operating Profit | 42 | 23 | 28 | +82.6% | +50.0% |
| OPM % | 22% | 17% | 18% | +500 bps | +400 bps |
| PAT | 15 | 20 | 16 | -25.0% | -6.3% |
| EPS (₹) | 16.72 | 30.61 | 25.82 | -45.4% | -35.2% |
The Plot Twist: Revenue up 37.5% YoY, operating margin expanded by 500 bps. But PAT is down 25% because Q4 FY24 had one-time Labour Code adjustments that inflated the base. Also, remember November’s MCIL acquisition consumed cash and attention. The real story isn’t Q4 PAT — it’s FY25 full-year revenue at ₹643 crore (+22.6%) and PAT at ₹75 crore (+18.9%). The P/E appears harsh at 45.4x, but you’re valuing a company that just became a fully integrated foundry solutions provider. Different ballgame now.
05 — Valuation: Fair Value Range
What’s This Metallurgical Marvel Actually Worth?
Method 1: P/E Based
FY25 full-year EPS = ₹95.91. Specialty chemicals sector median P/E = ~25x. Foseco’s margin profile (22% OPM) and ROCE justification: 1.4x–1.8x sector. Fair P/E band: 35x–45x.
Range: ₹3,357 – ₹4,316
Method 2: EV/EBITDA Based
FY25 EBITDA = ₹124 Cr. Current EV = ₹3,617 Cr → EV/EBITDA = 29.2x. Specialty chemicals peers trade at 18x–28x. Post-MCIL integration, likely compression toward 22x–26x.
EV range (22x–26x): ₹2,728 Cr – ₹3,224 Cr → Per share:
Range: ₹3,472 – ₹4,107
Method 3: DCF Based
Base FCF: ₹98 Cr (FY25 operating CF). Growth: 12–15% for 5 years (post-MCIL synergies). Terminal growth: 4%. WACC: 10%.
→ PV of 5-year FCFs at 10%: ~₹700 Cr
→ Terminal Value (4% growth / 6% cap rate): ~₹2,200 Cr
→ Total EV: ~₹2,900 Cr (near-zero net debt)
Range: ₹3,695 – ₹4,485
Fair Min: ₹3,400
CMP: ₹5,229
Fair Max: ₹4,500
CMP ₹5,229
⚠️ EduInvesting Fair Value Range: ₹3,400 – ₹4,500. CMP ₹5,229 trades at a premium to all three methods, pricing in aggressive MCIL synergy assumptions and near-term growth acceleration. This fair value range is for educational purposes only and is not investment advice. Please consult a SEBI-registered investment advisor before making any financial decision.
06 — What’s Cooking: The MCIL Masterstroke & Drama
Plot Twist: They Just Bought Their Biggest Complementary Asset
